Nilotinib - chemotherapy agent. Nilotinib is a selective Bcr/Abl tyrosine kinase inhibitor. This type of medicine is used in treatment ...
Nilotinib (AMN107, trade name Tasigna ), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...
Professional guide for Nilotinib. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.
This is an international site for TASIGNA® (Nilotinib) and is intended for Health Care Professionals outside the U.S. The information on the site is not country ...
This page contains brief information about nilotinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...
Information on the drug nilotinib (Tasigna) prescribed for the treatment of leukemia. Side effects, drug interactions, dosing information, and patient information is ...
Nilotinib (Tasigna®) for non-USA Residents
Nilotinib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Nilotinib is used to treat a type of blood cancer called ...
Nilotinib may cause QT prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death). Tell your ...
Tasigna (nilotinib) 150-mg and 200-mg capsules from Novartis is a treatment for Ph+ Chronic Myeloid Leukemia in newly diagnosed adult patients in chronic phase or ...